Researchers Identify Target with Potential to Improve CAR T-Cell Therapy Response in Patients with Blood Cancers
Every day, our faculty are conducting groundbreaking research, accelerating innovation and discovery in medicine.
Unparalleled resources prepare students to be physicians, scientists, and allied health professionals.
Providing compassionate, state-of-the-art patient care—not only in Baltimore, but throughout Maryland and the world.
The School of Medicine is a vital part of the West Baltimore neighborhood in which it resides, and we strive to bring a better quality of life to our neighbors.
Researchers Identify Target with Potential to Improve CAR T-Cell Therapy Response in Patients with Blood Cancers
Nationally Recognized Emergency Medicine Physician-Leader Michael E. Winters Named Chair of Emergency Medicine at UM School of Medicine
UMSOM receives $1 million in State Grant Funding to Build New Center for Combat Casualty Care
First-in-Human Clinical Trial Shows Promising Results for New Lassa Fever Vaccine
UM Greenebaum Comprehensive Cancer Center is First in Region to Offer Innovative Cell Therapy for Synovial Sarcoma
Bidding Farewell to the UMSOM Class of 2026
Five Minutes of Prayer Reduces Pain and Anxiety in Primary Care Patients, Randomized Trial Finds
Study Sheds Light On How Early Pancreas Lesions Become Cancerous
UM School of Medicine Receives $2.9 Million in Federal Funding for Advanced Microscopy to Accelerate Neuroscience Discoveries
Silver Spring Woman Becomes First Adult Sickle Cell Disease Patient in Maryland to Receive FDA-Approved Gene Therapy
Braxton Mitchell, PhD, MPH (Medicine), appeared on the Stat News First Opinion podcast to discuss rates of autism in the Amish community.
Justin Ortiz, MD, MS (Medicine), and UMSOM Dean Mark Gladwin, MD (Medicine), are quoted in an article about Dr. Ortiz's study on a vaccine that could protect against both rabies and Lassa fever.
Stephanie Knight, MD, (psychiatry) commented on the use of seclusion in patients committed to psychiatric care in state hospitals.
A WBAL-TV segment spotlighted the University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center as the first institution in the state to offer a novel treatment for synovial sarcoma, a rare form of cancer.
Kirsten Lyke, MD (Medicine) was interviewed about the ongoing Ebola virus outbreak in Africa.
Samuel Tisherman, MD (Surgery) was interviewed by WDCW-TV about the risks and symptoms of sepsis.
Jean Yared, MD, (Medicine) is featured in news stories profiling a sickle cell patient who was successfully treated for sickle cell disease using her own genetically-modified stem cells.
Andrea Levine, MD, (Medicine) spoke with WBAL-TV about her brain cancer diagnosis and participation in this year’s Half Marathon & 5K to raise money for the University of Maryland Greenebaum Comprehensive Cancer Center.
UMSOM study led by Jary Karri, MD, (Neurology) on the use of GLP-1 drugs to reduce knee osteoarthritis in obese individuals was covered by multiple outlets.
Sharon A. Hoover, PhD, (Psychiatry), was interviewed by Fox News about a new CDC report showing a rise in mental health issues in high school girls linked to social media.
Established through a generous lead gift from The Kahlert Foundation and cooperative funding by UMB, and UMSOM, this move for the Kahlert Institute for Addiction Medicine marks the start of a new era of pioneering research and clinical care.
Our Clinical Town Hall brought together faculty, residents, students, and staff to do what we do best — listen, collaborate, and move forward together. From clinical updates to open dialogue about the challenges we face every day, these conversations are what keep our community strong.
Dr. Forrester led a session on Understanding Trauma and Building Resilience, sharing practical tools support mental wellness. Dr. Jones presented on Creating the Conditions for Care: Supporting Community Resilience During Extreme Heat, highlighting ways to stay safe when temperatures rise.
The University of Maryland School of Medicine celebrated the Class of 2026 at commencement. These graduates entered medical school ready to learn and leave as physicians ready to lead. They've navigated challenges, built lifelong bonds, and grown into compassionate, skilled clinicians.
What a morning of miles, mentorship, and great conversation along Baltimore's Inner Harbor. Nothing like fresh air and shared strides to bring our community together. 🏃🏙️ #DeanGladwinOnTheMove
Was on Thursday, May 14, 2026, 1:00 pm, Hippodrome Theatre at the France-Merrick Performing Arts Center, 12 N. Eutaw St, Baltimore, MD 21201
Did you Know?
We achieved an historic, first-ever pig-to-human heart transplant in 2022.
Did you Know?
We were the first public medical school in the U.S.
Did you Know?
We were the first to build a teaching hospital and offer a residency program.
Did you Know?
We invented the field of “Shock Trauma.”
Did you Know?
We were the first to discover the relationship between insects and disease.
Did you Know?
We are one of the largest organ transplant centers in the U.S.
Did you Know?
We made vaccine breakthroughs around the world for COVID-19, Ebola, Zika, cholera, MERS/SARS, influenza, malaria and typhoid.
Did you Know?
We were the first to use a drone to deliver a kidney for transplantation.
Did you Know?
We were the first to test a unique RNA COVID-19 vaccine.
My experience at the University of Maryland School of Medicine was incredible. I am privileged to have learned from talented and dedicated faculty who spent countless hours developing a renaissance curriculum for us.
